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Available online 28 September 2016Background:Weexaminedmortality in schizophrenia spectrum disorder (SSD) and non-schizophrenic psychosis
(NSSD) compared to individuals without psychosis, and whether perinatal factors predict mortality.
Methods:Within Northern Finland Birth Cohort 1966 (n= 10 933; 203with SSD, 178with NSSD), mortality was
followed until end of 2011 by national register. Wantedness of pregnancy, mother's antenatal depression,
smoking and age, parity, paternal socio-economic status (SES) and family type at birthwere examined as predic-
tors of mortality.
Results:Mortality was higher in SSD (hazard ratio (HR) 3.60; 95% confidence interval (CI) 2.38–5.45) and NSSD
(4.05; 2.65–6.17) compared to personswithout psychoses after adjustment for gender. HR for natural death was
2.01 (0.82–4.91) in SSD and 4.63 (2.43–8.80) in NSSD after adjustment for gender. Corresponding figures for un-
natural deaths were 4.71 (2.94–7.54) and 2.94 (1.56–5.55), respectively. Among non-psychotic persons,
mother's depression, smoking and low SES predictedmortality after adjustment for gender and parental psycho-
ses (and SES), whereas among psychosis those whose father was a farmer had lower risk of mortality compared
to those with high SES.
Conclusions: Individuals with SSD had a higher risk of unnatural death and individuals with NSSD of natural and
unnatural deaths. Perinatal factors seem to bemore important predictors of mortality in individualswithout psy-
choses than with psychoses. According to population-based long follow-up data, it is important to pay attention
to somatic morbidity behind natural causes of death in psychoses and to prevent suicides in order to prevent ex-
cess mortality.




Excess mortality in psychotic disorders is a major public health con-
cern and therapeutic challenge (Crump et al., 2013b; Saha et al., 2007;
Termorshuizen et al., 2013;Walker et al., 2015; Ösby et al., 2000). Indi-
viduals with psychotic disorders have over a 2- to 4-fold higher all-
cause mortality risk than the general population (Crump et al., 2013b;
Høye et al., 2011; Kiviniemi et al., 2010; Lumme et al., 2016; Olfson etth Research, University of Oulu,
o.miettunen@oulu.fi
), tanja.nordstrom@oulu.fi
i.seppala@oulu.fi (J. Seppälä).al., 2015; Saha et al., 2007; Termorshuizen et al., 2013) and their life ex-
pectancy is 10–25 years lower (Crump et al., 2013b; Tiihonen et al.,
2009). Furthermore, those differences are continuing into old age
(Talaslahti et al., 2015).
Themortality rate is higher for natural and unnatural causes (Crump
et al., 2013b; Kiviniemi et al., 2010; Reininghaus et al., 2015; Ösby et al.,
2000). Common natural causes of death in schizophrenia are diseases of
the circulatory system (Brown et al., 2000; Bushe et al., 2010; Crump et
al., 2013b; Kiviniemi et al., 2010; Ösby et al., 2000), neoplasms (Brown
et al., 2000; Bushe et al., 2010; Crump et al., 2013b; Ösby et al., 2000),
diabetes (Crump et al., 2013b; Schoepf et al., 2014) and respiratory ill-
nesses (Crump et al., 2013b; Kredentser et al., 2014; Termorshuizen et
al., 2013; Ösby et al., 2000). About 2-fold ischemic heart disease and
1.5-fold cancer mortality risks have been shown in schizophrenia
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the digestive system, especially alcohol-related ones are also common
causes of death (Reininghaus et al., 2015). From the unnatural causes
of death, the leading cause is suicide (Brown et al., 2000; Reininghaus
et al., 2015) with the risk being 12- to 20-fold compared to the general
population (Reininghaus et al., 2015; Saha et al., 2007; Ösby et al.,
2000). Most of the suicides are committed during the first years after
the onset of psychoses (Alaräisänen et al., 2009; Ösby et al., 2000).
The risk for accidental/injury deaths is also higher for schizophrenia suf-
ferers than the general population (Crump et al., 2013a; Crump et al.,
2013b; Kredentser et al., 2014).
Few studies have examined differences in mortality in schizo-
phrenia and non-schizophrenic psychoses (Castagnini et al.,
2013; Healy et al., 2012). Individuals with schizophrenia may die
younger than those with other psychotic disorders (Healy et al.,
2012), but natural-cause mortality did not differ between schizo-
phrenia and acute and transient psychotic disorders (ATPD)
(Castagnini et al., 2013). However, individuals with ATPD were
more likely to commit suicide during the first year following the
initial episode than individuals with schizophrenia (Castagnini et
al., 2013).
Suggested reasons for excess mortality are unhealthy lifestyle
(Connolly and Kelly, 2005; Laursen et al., 2012; Ringen et al., 2014;
Suvisaari et al., 2013) and use (Joukamaa et al., 2006) or non-use of
antipsychotics (Tiihonen et al., 2016; Torniainen et al., 2015). Stud-
ies have mainly focused on predictors of mortality prevalent in the
later stages of life (Fazel et al., 2014; Joukamaa et al., 2006;
Suvisaari et al., 2013; Tiihonen et al., 2016) reporting that self-
harm, alcohol/drug use disorders (Fazel et al., 2014), older age at
onset of schizophrenia, long duration of illness and inability to
work are predictors of mortality (Ran et al., 2007). More information
also from earlier stages of life is needed. As far as we know, paternal
older age in women (Miller et al., 2010) and lower maternal educa-
tion have predicted mortality in psychoses (Dickerson et al., 2016).
Furthermore, birth complications in men have predicted mortality
in psychoses (Fazel et al., 2014). Because deviances in environment
in early life are risk factors for schizophrenia (Laurens et al., 2015;
Matheson et al., 2011), it is important to study whether they also
predict prognosis of psychoses.
The aim of this study was to examine mortality and causes of
death in schizophrenia spectrum disorder (SSD) and non-schizo-
phrenic psychoses (NSSD) compared to individuals without
psychosis and whether perinatal circumstances predict mortality in
all psychoses. We hypothesized that unwanted pregnancy, mother's
antenatal depression and smoking, mother's young or old age, low or
high parity, low paternal socio-economic status (SES) and single-
parent family at birth would increase the risk of mortality.
2. Methods
This study is based on the Northern Finland Birth Cohort 1966
(NFBC1966) concerning 12,058 live-born children in 1966 in the
provinces of Oulu and Lapland (Rantakallio, 1969). Individuals, who
were alive and living in Finland at the age of 16 years (n = 11,017)
were included in this study. Overall, 84 of them denied use of their
data, thus leading to the sample of 10,933 individuals. Study design
was approved by the Ethical Committee of the Northern Ostrobothnia
Hospital District, and Ministry of Social and Health Affairs gave
permission to gather the data.
2.1. Psychoses
Psychoses are based on the registers of Statistics Finland (Care
Register for Health Care (CRHC), formerly the Finnish Hospital
Discharge Register, followed until the end of 2011, the Register of
Specialty Outpatient Health Care from 1998 until 2011 and PrimaryCare Outpatient Register from 2011) and Register of the Finnish Cen-
tre for Pensions (FCP) until 2011 and the Registers of the Social In-
surance Institution (reimbursed medicine until 2005, pension until
2000 and sick days until the end of 1999).
Individuals were classified as having SSD (ICD-8 (1968–1986): 295,
ICD-9 (1987–1995): 295, 2954, 2957, 297 and ICD-10 (1996–2013):
F20, F22, F25), other NSSD (psychotic bipolar disorder (ICD-8: 2961–
2969, ICD-9: 2962E, 2963E, 2964E, 2967, ICD-10: F30.2, F31.2, F31.5))
psychotic depression (ICD-8: 2960, 2980, ICD-9: 2961E, ICD-10: F32.3,
F33.3) brief/reactive psychosis (ICD-8: 2981–2983, 2988, 2989, ICD-9:
2988, ICD-10: F23) and other psychosis (ICD-8: 299, ICD-9: 2989, ICD-
10: F28, F29)) and without psychosis. Overall, 203 individuals had SSD
(narrow ICD-8 & 9: 2950–2953, 2955, 2956, 2958, 2959, 295, ICD-10:
F20 n = 149, spectrum ICD-8 & 9: 2954, 2957, 297, ICD-10: F22, F24,
F25 n= 54) and 178 NSSD (psychotic bipolar disease n= 22, psychotic
depression n = 62, brief or reactive psychosis n = 29 and undefined
other psychosis n= 65). For further analyses, SSD and NSSDwere com-
bined as having psychosis.
2.2. Causes of mortality
Information on time and causes of death until 31st December 2011
were obtained from the Cause of Death Register from the Statistics Fin-
land. The register contains data from death certificates (Lahti and
Penttilä, 2001). Causes of death were classified according to ICD-8, 9
or 10, depending on the time of the death (Table 2). From the external
causes of morbidity and mortality, suicide or intentional self-harm
was classified in its own class. Classes from infections to congenital
malformations, deformations and chromosomal abnormalities were
classified as natural and classes concerning external causes of
morbidity/mortality and suicide to unnatural causes of death (Table
2). Classes concerning symptoms, signs and abnormal clinical findings
and no basic statistical cause of death were defined as unknown causes
of death.
2.3. Predictors of mortality
We selected as predictors of mortality the same variables from
perinatal circumstances, which have been studied earlier as
predictors of suicides in the NFBC1966 (Alaräisänen et al., 2012).
Data on perinatal circumstances were gathered by interviews
conducted by nurses with the help of questionnaires duringmothers'
visits to antenatal clinics at gestation weeks of 24–28 and from the
Population Register Centre (PRC).
Wantedness of pregnancy was asked with the question, whether
mothers had wanted the pregnancy, would have preferred it later or
had not wanted. Responses were dichotomized to wanted/mistimed
or unwanted (Myhrman et al., 1996).
Mother's antenatal depressed mood was asked with the question,
whether they felt that their mood was normal, depressed or very
depressed during pregnancy. Responses were classified to normal
and depressed (Alaräisänen et al., 2012).
Mother's smoking during pregnancywas classified as no, if she did not
smoke or had stopped before the pregnancy and yes, if she had smoked
at least one cigarette daily (Mäki et al., 2010).
Mother's age at birthwas received from the PRC andwas classified as
under 20 years, 20–35 years and over 35 years (Keskinen et al., 2013).
Parity at birthwas classified as 1, 2–5 and over 5 (Alaräisänen et al.,
2012).
Family type at birth was based on the marital status of the mother
during pregnancy (married, divorced, widowed and never married)
andwas classified as two-parent families (full) or single-parent families
(Alaräisänen et al., 2012).
SES at birthwas based on the father's occupation and were classified
as high (classes I and II), low (classes III and IV) and farmers (class V)
(Alaräisänen et al., 2012).
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psychosis (i.e. ICD-8: 295–299; ICD-9: 295, 2961E, 2962E, 2963E,
2964E, 2967 and 297–299; ICD-10: F20 and F22-F29) based on the
CRHC (1972–2012), Specialized Outpatient Care Register (1998–
2012), Register of Primary Health Care Visits (2011−2012), and FCP
(disability pensions, 1964–2011).
Duration of illnesswas calculated by using the date of death and the
date of onset of psychosis based on the registry entry.2.4. Statistical analyses
Analyses were conducted by IBM SPSS Statistics 22 (SPSS., Inc.,
and IBM company, 1989, 2013). Gender, perinatal circumstances,
parental psychosis and causes of death between individuals with
SSD, NSSD and without psychoses were examined by using cross-
tabulation and χ2- exact tests. Cox regression analyses were
used to examine mortality according to perinatal circumstances,
after adjustment for gender, parental psychosis and SES at birth
in psychoses and without psychoses. Natural and unnatural
death were examined according to duration of illnesses in SSD
and NSSD. The results are expressed as hazard ratios (HRs) with
95% confidence intervals (95% CIs). Date of death, date of
emigration or end of the follow-up 31st December 2011 was set
as an end-point, whichever came sooner in the analyses.
Furthermore, interactions between statistically significant
predictors and diagnosis groups in psychoses (SSD vs. NSSD)
were tested.Table 1
Gender, perinatal circumstances and parental psychosis in schizophrenia spectrum disorder (S








n % n % n
Gender
Men 118 58.1 96 53.9 214
Women 85 41.9 82 46.1 167
Wantedness of pregnancy
Wanted/mistimed 160 81.6 144 84.2 304
Unwanted 36 18.4 27 15.8 63
Mothers' antenatal depressed mood
Normal 160 81.6 141 81.5 301
Depressed 36 18.4 32 18.5 68
Mother's smoking during pregnancy
No 169 87.1 131 78.0 300
Yes 25 12.9 37 22.0 62
Mother's age at birth
b20 years 16 7.9 17 9.6 33
20–35 years 145 71.4 132 74.2 277
N35 years 42 20.7 29 16.3 71
Parity at birth
1 66 32.7 52 29.4 118
2–5 103 51.0 98 55.4 201
6 or more 33 16.3 27 15.3 60
Family type at birth
Full 193 95.1 168 94.4 361
Single 10 4.9 10 5.6 20
Paternal socio-economic status at birth
High (I–II) 18 8.9 8 4.5 26
Low (III–IV) 155 76.7 134 75.3 289
Farmer (V) 29 14.4 36 20.2 65
Parental psychosis
No 169 83.3 148 83.1 317
Yes 34 16.7 30 16.9 643. Results
Individuals with SSD were more often men and unwanted during
pregnancy than those without psychoses (Table 1). Mothers of individ-
uals with NSSD were more often smokers during pregnancy than those
without psychoses. Overall, personswith psychosisweremore often the
offspring of mothers with antenatal depression and the offspring of a
parent with psychoses (Table 1).
3.1. Mortality and causes of death
Overall, 3.5% of cohort members had died by the age of 45 years:
11.8% with SSD, 12.9% with NSSD and 3.2% without psychoses (Table
2, Fig. 1). Mortality risk was 3.60-fold (95% CI 2.38–5.45) in SSD and
4.05-fold (95% CI 2.65–6.17) in NSSD compared to those without
psychosis after adjustment for gender. Overall, mortality risk was
3.80-fold (95% CI 2.80–5.16) in all psychoses compared to those
without psychosis after adjustment for gender.
20.8% of deaths were due to natural causes among individuals
with SSD, 43.5% among those with NSSD and 38.6% among those
without psychoses. Corresponding figures for unnatural causes
were 79.2% 43.5% and 59.0%, respectively (Table 2). Individuals
with SSD had 2.01-fold (95% CI 0.82–4.91) and NSSD 4.63-fold (95%
CI 2.43–8.80) risk for natural death compared to non-psychotic
individuals after adjustment for gender. Correspondingly, persons
with SSD had 4.71-fold (95% CI 2.94–7.54) and NSSD 2.94-fold (95%
CI 1.56–5.55) risk for unnatural death. Overall, the risk of natural
(HR 3.23, 95% CI 1.89–5.51) and unnatural death (HR 3.90, 95% CISD), non-schizophrenic psychosis (NSSD), all psychosis and no psychosis at the Northern









56.2 5375 50.9 0.047 0.450 0.047
43.8 5177 49.1
82.8 9080 88.4 0.005 0.117 0.002
17.2 1197 11.6
81.6 8871 86.2 0.075 0.076 0.012
18.4 1417 13.8
82.9 8628 85.1 0.477 0.012 0.260
17.1 1506 14.9
8.7 994 9.4 0.293 0.992 0.602
72.7 7764 73.7
18.6 1771 16.8
31.1 3381 32.1 0.113 0.342 0.060
53.0 5910 56.1
15.8 1246 11.8
94.8 10,187 96.5 0.331 0.143 0.066
5.2 365 3.5
6.8 763 7.3 0.171 0.366 0.517
76.1 7719 73.5
17.1 2023 19.3
83.2 9878 93.6 b0.001 b0.001 b0.001
16.8 674 6.4
Table 2
Causes of death (according to ICD-8, 9 and 10 categories) in individuals with schizophrenia spectrum disorder (SSD), non-schizophrenic psychoses (NSSD) and without psychoses













n % n % n % n %
Infections 0 0 0 0 0 0 1 0.3
Neoplasms 0 0 2 8.7 2 4.3 37 10.9
Endocrine, nutritional and metabolic diseased 0 0 2 8.7 2 4.3 5 1.5
Mental, behavioural and neurodevelopmental diseasesa 1 4.2 0 0 1 2.1 6 1.8
Diseases of the nervous system 0 0 0 0 0 0 14 4.1
Diseases of the circulatory system 4 16.7 4 17.4 8 17.0 35 10.3
Diseases of the respiratory system 0 0 0 0 0 0 8 2.4
Diseases of the digestive system 0 0 2 8.7 2 4.3 16 4.7
Diseases of the musculoskeletal system and connective tissue 0 0 0 0 0 0 2 0.6
Diseases of the genitourinary system 0 0 0 0 0 0 1 0.3
Pregnancy childbirth and the puerperium 0 0 0 0 0 0 2 0.6
Congenital malformations, deformations and chromosomal abnormalities 0 0 0 0 0 0 4 1.2
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedb 0 0 3 13.0 3 6.4 0 0
External causes of morbidity/mortality 8 33.3 2 8.7 10 21.3 116 34.2
Suicides 11 45.8 8 34.8 19 40.4 84 24.8
No basic statistical cause of death 0 0 0 0 0 0 8 2.4
a Cause of death was alcohol dependence in all 7 cases.
b Cause was unspecified cause of mortality in all three individuals.
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adjustment for gender. Fig. 2 presents natural and unnatural mortality
according to duration of illness in individuals with SSD and NSSD.
3.2. Parental psychoses and perinatal circumstances as predictors of mor-
tality in individuals with psychosis or without psychoses
Parental history of psychoses did not seem to predict mortality in
psychoses (HR 1.28, 95% CI 0.62–2.66) contrary to non-psychosesFig. 1. Survival curve for all-cause mortality in individuals with schizophrenia spectrum disord
45 years until the end of 2011.(HR 1.74, 95% CI 1.23–2.47) after adjustment for gender. In
individuals with psychoses, those whose father belonged to SES
class of farmers (V) had a lower risk of mortality than individuals,
whose father belonged to a high SES class (I–II) even after
adjustment for gender and parental psychoses (Table 3). There was
no interaction between paternal SES and diagnosis of psychoses. In
individuals without psychoses, mother's antenatal depression,
mothers smoking during pregnancy and SES (III–IV, V) predicted
higher mortality even after adjustments (Table 3).er (SSD), other non-schizophrenic psychoses (NSSD) and without psychoses by the age of
Fig. 2. Natural and unnatural mortality from the onset of psychoses according to schizophrenia spectrum disorder (SSD) and other non-schizophrenic psychoses (NSSD).
Table 3
Perinatal circumstances as predictors of all-cause mortality until 31st December 2011 in
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HR = hazard ratio, CI = confidence interval.
a Adjusted for gender, socio-economic status at birth and parental psychoses.
b Adjusted for gender and parental psychosis.
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4.1. Main results
Individuals with SSD and NSSD had about a 4-fold mortality risk
compared to those without psychoses. Individuals with NSSD had over
4.5-fold risk for natural death compared to non-psychotic individuals
and the most common cause was diseases of the circulatory system.
The risk of unnatural death was over 4.5-fold in individuals with SSD
and almost 3.0-fold with NSSD compared to non-psychotic individuals.
Suicide was a cause of death for nearly half of the persons with SSD, for
about one thirdwith NSSD and one quarter of those without psychoses.
In individuals with psychoses, those whose father belonged to the SES
class of farmers had a lower risk ofmortality than individuals, whose fa-
ther belonged to a high SES class. Instead, in individuals without psy-
choses, mother's antenatal depression and smoking during pregnancy
as well as paternal low SES predicted higher mortality.
4.2. Comparison with previous research
Our results concerning excess mortality in psychosis is in line with
the earlier studies (Kiviniemi et al., 2010; Kredentser et al., 2014;
Reininghaus et al., 2015; Saha et al., 2007). However, our results high-
light the greater occurrence of somatic diseases behind natural causes
of death in NSSD compared to those without psychoses. It could be
that higher natural mortality in NSSD is due to delayed diagnosis or
treatment of somatic illness. For example, individuals with schizophre-
nia expressed physical complaints at more serious stages of the illness
(Oud and De Meyboom, 2009) and despite having twice as many
healthcare contacts, they were not diagnosed with ischemic heart dis-
ease, and they had elevated mortality risk due to this condition
(Crump et al., 2013b).
Interestingly, individuals with psychosis, whose father was a farmer
had lower mortality than individuals, whose father had a higher SES.
This result may be a chance finding or partly due to living environment
as individuals with schizophrenia born in rural areas may have in gen-
eral better outcomes, e.g. a good employment outcome (Munk-
Jørgensen and Mortensen, 1992). The result differs from our result
concerning non-psychotic individuals showing that individuals with
low paternal SES had a higher mortality risk than those with a high
SES. This is in line with the results of the systematic review concerning
the general population (Galobardes et al., 2008). The low number of in-
dividuals with psychoses whose father was a farmermay have an effect
on the results and in general farmswere small in 1966 in Finland. There
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choses than with psychoses. It seems that deviances in early life envi-
ronment may not be predictors of prognosis of psychoses. The course
of psychoses during life-course is complex and does not follow the
same kind of continuum as in individuals without psychoses.4.3. Strengths and limitations of the study
The strengths of the study were that NFBC1966 was a population-
based cohort study and we were able to focus also on individuals with
NSSD, who are studied less often (Castagnini et al., 2013; Healy et al.,
2012). Prospective collection of datawas unique (Rantakallio, 1969) ap-
plying to study perinatal circumstances as predictors of mortality in a
long 45-year follow-up. In studies where participants are older, mortal-
ity due to diseases is more often detected alongwith suicides, which are
the usual causes of death during the first years after mental illness
(Bushe et al., 2010; Räsänen et al., 1998; Ösby et al., 2000).
Limitations include that we were not able to study specific causes of
mortality, because of the small number of cases. It may be also so that
the longer the follow-up is, the worse the predictive power of early
life factors, especially in individuals with psychoses, whose onset of ill-
ness was later. Mediating factors near the onset of psychoses maybe
more important predictors of mortality (Suvisaari et al., 2013; Fazel et
al., 2014; Joukamaa et al., 2006; Ran et al., 2007; Tiihonen et al., 2016),
whichwas not the focus of our study. Due to the small number of deaths
in women with psychoses we were not able to conduct gender-specific
analyses. In addition, in the analyses there were no adjustments for
multiple comparisons.5. Conclusions
Individuals with psychosis, also in NSSD, had excess mortality com-
pared to individuals without psychosis. As already known, individuals
with SSD had a higher risk of unnatural death compared to those with-
out psychoses. A new finding is that individuals with NSSD had over a
4.5-fold risk of natural death than individuals without psychoses. Peri-
natal circumstances seem to be more important predictors of mortality
in individuals without psychoses than with psychoses, describing the
complex trajectory of course and severity of illness in psychoses. It is im-
portant to pay attention to early diagnosis and adequate follow-up and
treatment of somatic morbidity not only in SSD, but also in NSSD. In ad-
dition, we should improve access to healthcare and prevent suicides in
individuals with psychoses in order to prevent their excess mortality.Conflicts of interest
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